U.S. Stocks to Watch: Qualcomm, Apple, Intel, Organon, X-Energy, and More

Tiger Newspress18:30

Stock futures were sliding on Monday, with investors on edge ahead of a slew of Big Tech earnings and a Federal Reserve interest-rate decision.

These stocks were making moves in premarket trading.

Qualcomm jumped 9.7% after tech supply chain analyst Ming-Chi Quo said that OpenAI was working with the chip maker to develop processors for a smartphone, with mass production expected to start in 2028. Shares in iPhone maker Apple slid 1.2%. Qualcomm and OpenAI didn’t immediately respond to requests for comment from Barron’s.

Intel rose 3.2%, extending the chip manufacturer’s stellar recent rally. The stock surged 24% on Friday after Intel reported strong first-quarter earnings, notching its first record close since August 2000.

Adidas climbed 1.8% after Kenya’s Sabastian Sawe won Sunday’s London marathon, becoming the first competitive runner ever to complete the race in under two hours. Sawe wore Adidas sneakers—although the $500 shoe isn’t yet widely available.

Organon surged 15% to $12.96 after India’s Sun Pharmaceutical Industries agreed to buy the women’s healthcare company for $14 a share, in an all-cash deal with an enterprise valuation of $11.75 billion.

X-Energy rallied 16%, after the Amazon-backed nuclear reactor developer jumped 27% in its trading debut on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment